Sei Won Kim Selected Research

Sei Won Kim Research Topics

Disease

5	Hypoxia (Hypoxemia) 11/2023 - 01/2018
4	Neoplasms (Cancer) 01/2023 - 01/2015
3	Acute Lung Injury 01/2023 - 02/2020
3	Bronchiolitis Obliterans Syndrome 01/2017 - 01/2016
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2015
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2023 - 12/2020
2	Fibrosis (Cirrhosis) 11/2023 - 05/2016
2	Inflammation (Inflammations) 11/2023 - 01/2017
2	COVID-19 07/2022 - 02/2022
2	Pain (Aches) 05/2021 - 11/2020
2	Lung Injury 12/2020 - 02/2020
2	Obstructive Sleep Apnea 11/2020 - 08/2020
2	Respiratory Insufficiency (Respiratory Failure) 05/2020 - 02/2020
2	Hyperoxia 02/2020 - 01/2018
2	Asthma (Bronchial Asthma) 01/2017 - 01/2014
1	Apnea 01/2023
1	Sepsis (Septicemia) 01/2022
1	Insulin Resistance 08/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Hyperventilation 10/2017
1	Chronic Bronchitis 01/2017
1	Pneumonia (Pneumonitis) 05/2016
1	Lymphoma (Lymphomas) 01/2015
1	Neutropenia 01/2015
1	Osteoporosis 01/2015
1	Rupture 01/2015
1	Pulmonary Atelectasis 01/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014
1	Tracheal Stenosis 06/2012
1	Pathologic Constriction (Stenosis) 06/2012
1	Airway Obstruction (Choking) 06/2012
1	Tuberculosis (Tuberculoses) 06/2012

Drug/Important Bio-Agent (IBA)

4	Oxygen (Dioxygen)IBA 01/2023 - 01/2018
3	LipopolysaccharidesIBA 01/2023 - 02/2020
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017 - 05/2016
2	RoflumilastIBA 01/2017 - 05/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023
1	Neutralizing AntibodiesIBA 07/2022
1	molnupiravirIBA 02/2022
1	C-Reactive ProteinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Inflammation MediatorsIBA 01/2022
1	ProcalcitoninIBA 01/2022
1	indium-bleomycinIBA 12/2020
1	Triglycerides (Triacylglycerol)IBA 08/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2020
1	ParaffinIBA 02/2020
1	Hematoxylin (Haematoxylon)IBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	CateninsIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Mannitol (Osmitrol)FDA LinkGeneric 10/2017
1	Adenosine (Adenocard)FDA LinkGeneric 10/2017
1	Interleukin-33IBA 01/2017
1	InterleukinsIBA 01/2017
1	CytokinesIBA 05/2016
1	montelukast (Singulair)FDA Link 01/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2016
1	Therapeutic UsesIBA 01/2016
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Formoterol Fumarate (Oxis)FDA Link 01/2016
1	GATIBA 01/2015
1	SteroidsIBA 01/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	Alkaline PhosphataseIBA 01/2015
1	25-hydroxyvitamin DIBA 01/2015
1	Illicit Drugs (Recreational Drugs)IBA 01/2014
1	SiliconesIBA 06/2012

Therapy/Procedure

6	Therapeutics 07/2022 - 01/2016
3	Artificial Respiration (Mechanical Ventilation) 07/2022 - 11/2020
3	Hematopoietic Stem Cell Transplantation 05/2016 - 01/2015
2	Stents 01/2015 - 06/2012
1	Cannula 07/2022
1	Critical Care (Surgical Intensive Care) 07/2022
1	Noninvasive Ventilation 05/2020
1	Drug Therapy (Chemotherapy) 01/2015
1	Self Expandable Metallic Stents 01/2015
1	Electrocoagulation (Electrocautery) 06/2012